Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-03

Clinical Trial Update: Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on the recombinant herpes zoster vaccine in patients with autoimmune rheumatic diseases; the study is active but not recruiting an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Shingrix (recombinant zoster vaccine, adjuvanted)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Rheumatoid Arthritis, Spondylitis, Ankylosing | Phase 4 | Status: ACTIVE_NOT_RECRUITING